Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions.

MLA

Cannalire, Rolando, et al. “Broad Spectrum Anti-Flavivirus Pyridobenzothiazolones Leading to Less Infective Virions.” Antiviral Research, vol. 167, July 2019, pp. 6–12. EBSCOhost, https://doi.org/10.1016/j.antiviral.2019.03.004.

APA

Cannalire, R., Tarantino, D., Piorkowski, G., Carletti, T., Massari, S., Felicetti, T., Barreca, M. L., Sabatini, S., Tabarrini, O., Marcello, A., Milani, M., Cecchetti, V., Mastrangelo, E., Manfroni, G., & Querat, G. (2019). Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions. Antiviral Research, 167, 6–12. https://doi.org/10.1016/j.antiviral.2019.03.004

Chicago

Cannalire, Rolando, Delia Tarantino, Geraldine Piorkowski, Tea Carletti, Serena Massari, Tommaso Felicetti, Maria Letizia Barreca, et al. 2019. “Broad Spectrum Anti-Flavivirus Pyridobenzothiazolones Leading to Less Infective Virions.” Antiviral Research 167 (July): 6–12. doi:10.1016/j.antiviral.2019.03.004.